John Neustadt, ND - Acamnet.com acamnet

Recommendations

Info

F-N'$"%'&N=$*/$.(50N%-"* Drug Fracture risk reduction Alendronate (Fosamax) 10 mg 47%, all vertebra Risedronate (Actonel) 5 mg 49%, all vertebra Ibandronate (Boniva) 2.5 mg qd or 150 mg qmo 52%, all vertebra Raloxifene (Evista) 60 mg 30%, all vertebra Parathyroid hormone 20 mcg to 40 mcg 65% to 69%, respectively, all vertebra
F-N'$"%'&N=$*/$.")* E'05#4'$*3("C*3$.45N%-*:(#0N%-"* !,+6Y'-(5'@4;;)%8.'[e5'f+*AO'-!5'"/'+,
Page 1 and 2: John Neustadt, ND Osteoporosis: Bey
Page 3 and 4: !"#$%&%'%"(")* +$,%-.*+%-$*/(-$'01*
Page 5 and 6: 3$"%4'5$"*65%-#7.8*
Page 7: '2+9"'$./"$A"%)+'2+9"'$./"$A$*$.).'
Page 10 and 11: AB0#7"*#B$*'$01*'("CD** E3FGHIHJK*E
Page 12 and 13: E'05#4'$"*65%-#7.8* ! JEEHM'3$%9"*/
Page 14 and 15: E;*0-.*/%'#01(#,*3("C*65%-#7.8* ! J
Page 16 and 17: H"*+/2*'A40,).2"&'+'A$.)/)$%'./+/";
Page 18 and 19: AB0#*("*P%-$D* ! @$;A,"d5',)9)%8'/)
Page 20 and 21: +%-$*JB'%4QB%4#*I(O$* ! @2),&2$$&'/
Page 22 and 23: 3("C"*O%'*!"#$%&%'%"("*0-.*E'05#4'$
Page 24 and 25: G145%5%'N5%(."*65%-#7.8* ! R*+,'8,4
Page 26 and 27: 9%>%5,"#$(-$*0-.*9(&*E;* ! W6#'+.'+
Page 28 and 29: :%R$$*0-.*!"#$%&%'%"("*65%-#7.8* !
Page 30 and 31: :0.>(4>*J%;(5(#,*65%-#7.8* ! @2*$%)
Page 32 and 33: SF/@*E'05#4'$*3("C*E05#%'"* ! N&9+%
Page 34 and 35: ' ="$#%&-+)-9)%)-9):&;)9
Page 36 and 37: F:!G*!"#$%&%'%"("*3("C*E05#%'"* *(F
Page 38 and 39: F:!G*!"#$%&%'%"("*3("C*E05#%'"* *(F
Page 40 and 41: F..(N%-01*3("C"*6-%#*F:!G8* ! @+&;)
Page 42 and 43: SF/@*3$5%>>$-.0N%-"* ! `)82/)%8' !
Page 44 and 45: !"#$%&%'%"("*3("C*' ! ,(&L:%K)`$..'
Page 46: !"#$%5015(-* ! a%&"*6+*0$d#,+/"&'$.
Page 51 and 52: F-N'$"%'&N=$*/$."*65%-#7.8* ! ?*"+/
Page 53 and 54: F-N'$"%'&N=$*/$."*65%-#7.8* ! ["6$%
Page 55 and 56: 2($#)*:%&&$'*0-.*X(-5* ! x)%6' ! :"
Page 57 and 58: M;$'5("$*65%-#7.8* ! R%"'#"+*'$O'L"
Page 59 and 60: W(#0>(-*V*65%-#7.8* ! P)/+;)%'fQ'+%
Page 61 and 62: W(#0>(-*V* ! fQM'A*"O"*"%/)+,,#'4."
Page 63 and 64: W(#*V)*@0O$#,*:(#0N%-"* N.+Y4*+'W5'
Page 65 and 66: W(#0>(-*V[* ! [/4&#'&".)8%M'$0."*9+
Page 67 and 68: M0#*K%4'*G'$$-"* ! :2#,,$h4)%$%"'6$
Page 69 and 70: V\*O%'*' `"4A*$,)&"'=+'o%eW'+8$%)./
Page 71 and 72: V\*0-.*E'05#4'$"* :1(-(501*J'(01*[*
Page 73 and 74: V\*0-.*E'05#4'$"* :1(-(501*J'(01*Y*
Page 75 and 76: @#'%-N4>*'0-$10#$*6@38* ! ?2"'O$*;'
Page 77 and 78: @3*:1(-(501*J'(01*[*65%-#7.8* ! o*$
Page 79 and 80: @3*:1(-(501*J'(01*[*65%-#7.8* ! e".
Page 81 and 82: @3*:1(-(501*J'(01*Y*65%-#7.8* ! e".
Page 83 and 84: E;*3("C*3$.45N%-)* :1(-(501*J'(01"*
Page 85: :%-514"(%-* ! 7/c.'/);"'/$';$9"'0"#

John Neustadt, ND - Acamnet.com acamnet

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?